Digital Therapeutics for Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help young people quit vaping through a digital app called quitSTART, specifically adapted for vaping cessation. Participants will use a version of the app that includes a chatbot feature for personalized support and encouragement. The goal is to evaluate the effectiveness of this intervention in reducing vaping among teens and young adults. Those who currently vape, have a smartphone, and discuss quitting online or have health issues from vaping might be suitable for this study. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to experience this innovative approach first.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using a digital app to help quit vaping.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the quitSTART mobile app, designed to help people stop smoking, is safe. The app offers tips and encouragement to quit smoking, with no reports of harm from its use.
Studies have found that the chatbot feature in the quitSTART app can increase motivation to quit vaping and smoking. These chatbots engage users through short, helpful conversations. They are also used in other tools to aid smoking cessation and are generally considered safe.
This trial is in the early stages, focusing on ensuring the app and chatbot are safe and comfortable for users. Since the app and chatbot are not drugs or medical devices, they lack the side effects associated with medications. Overall, evidence suggests that both the app and the chatbot feature are safe for users.12345Why are researchers excited about this trial?
Researchers are excited about these digital therapies for vaping cessation because they introduce innovative methods in supporting young adults to quit vaping. Unlike traditional options, which often involve counseling or nicotine replacement therapies, the quitSTART Mobile Application offers a mobile-based approach. Particularly, the experimental version includes an embedded chatbot feature that provides personalized, real-time support and motivation, making it more engaging and accessible. This tech-driven approach leverages the widespread use of smartphones among young adults, providing a potentially more effective and convenient resource for quitting vaping.
What evidence suggests that this trial's treatments could be effective for vaping cessation?
Research has shown that digital tools like the quitSTART mobile app can help people quit smoking, and similar success is expected for quitting vaping. In this trial, participants in Experimental Group A will use the quitSTART Mobile Application adapted for vaping cessation. Participants in Experimental Group B will use the same app with an embedded chatbot feature. The app provides personalized tips and encouragement based on smoking or vaping habits. Studies have found that customized digital tools, like quitSTART, keep users engaged and support their efforts to quit. The app also includes a chatbot feature to boost motivation and provide helpful content. This method is especially promising for young adults who seek privacy and support through their phones.678910
Are You a Good Fit for This Trial?
This trial is for U.S. residents who speak English, use vaping products daily, and have a smartphone. Participants should be networking about quitting or facing health issues from vaping but not using it to quit smoking.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with a mobile app intervention adapted for vaping cessation, including an embedded chatbot feature to guide and motivate cessation efforts
Follow-up
Participants are monitored for vaping cessation and engagement with the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Chatbot Feature in quitSTART Mobile Application
- quitSTART Mobile Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
University of South Carolina
Collaborator